BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hesperos Inc. - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hesperos Inc.
X-ORIGINAL-URL:https://hesperosinc.com
X-WR-CALDESC:Events for Hesperos Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260205T110000
DTEND;TZID=UTC:20260205T120000
DTSTAMP:20260525T115522
CREATED:20260203T171253Z
LAST-MODIFIED:20260203T213343Z
UID:3507-1770289200-1770292800@hesperosinc.com
SUMMARY:Webinar:  Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity
DESCRIPTION:James J. Hickman\, Chief Scientist at Hesperos\, will be presenting at the upcoming webinar: Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity. Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation. \nA major challenge in drug discovery and toxicology is the gap between cell-level studies and whole-animal or human systems.  Researchers are now creating miniaturized human-on-a-chip systems where human-derived cells connect and function in ways that reflect real tissue and organ behavior\, enabling more accurate evaluation of drug efficacy and safety. \nIn this webinar\, James Hickman will discuss developing advanced multi-organ human-on-a-chip systems that model neural\, muscle\, and cardiac subsystems and how these platforms can inform preclinical decision-making. \nTopics to be covered: \n\nDesign\, fabrication\, and validation of multi-organ human-on-a-chip\nModeling motor\, cognitive\, muscle\, and cardiac functions\nApplications in preclinical drug discovery and toxicity testing\n\nClick HERE to register!
URL:https://hesperosinc.com/event/multi-organ-human-on-a-chip-systems-for-predicting-drug-efficacy-and-toxicity/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/02/DDN-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251206
DTSTAMP:20260525T115522
CREATED:20251107T215334Z
LAST-MODIFIED:20251110T164829Z
UID:3363-1764892800-1764979199@hesperosinc.com
SUMMARY:The 3Rs Collaborative & IQ-Consortium: Microphysiological Systems Webinar & Workshop Series
DESCRIPTION:Webinar: Microphysiological Systems Webinar & Workshop Series\nWednesday\, December 3\, 2025\n10 am-12:30 p.m. (EST)\nInvited Speaker\nJ Hickman\, PhD\, Chief Scientist \n  \nAbout the webinar: 3RsC MPS in Drug Development program is an initiative by The 3Rs Collaborative (3RsC) to advance the adoption and regulatory acceptance of Microphysiological Systems (MPS) technologies\, in alignment with the principles of the 3Rs (Replacement\, Reduction\, and Refinement) in animal research. 
URL:https://hesperosinc.com/event/the-3rs-collaborative-iq-consortium-microphysiological-systems-webinar-workshop-series/
LOCATION:The Three Rs Collaborative\, United States
CATEGORIES:Invited Speaker,Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/11/Na3rc-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250904T110000
DTEND;TZID=UTC:20250904T120000
DTSTAMP:20260525T115522
CREATED:20250829T193950Z
LAST-MODIFIED:20250829T194326Z
UID:3199-1756983600-1756987200@hesperosinc.com
SUMMARY:Webinar:  Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling
DESCRIPTION:Summary\nThe pharmaceutical industry is transitioning away from animal tests\, per the recent FDA Roadmap. Scientists’ need for drug development insights without animals has spurred greater interest in New Approach Methodologies (NAMs)\, such as in silico modeling and in vitro assays like organ-on-a-chip. \nThis webinar will explore how Human-on-a-Chip (HoaC) systems—combined with physiologically-based pharmacokinetic (PBPK) modeling—enable a powerful\, human-relevant approach to predicting safety and efficacy in drug development. Speakers will showcase how HoaC data can be translated into in vivo outcomes using biosimulation\, with case studies illustrating regulatory and program-level impact. \nWho should attend: \nR&D and translational leaders in biotech and pharma\nToxicologists and DMPK scientists\nClinical pharmacologists and regulatory professionals\nModeling & simulation experts \nClick here to register
URL:https://hesperosinc.com/event/webinar-insights-without-animals-leveraging-human-on-a-chip-pbpk-modeling/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://hesperosinc.com/wp-content/uploads/2025/08/Screenshot-2025-08-29-134250.png
END:VEVENT
END:VCALENDAR